Singulair and Hepatitis - a phase IV clinical study of FDA data
Summary:
Hepatitis is reported as a side effect among people who take Singulair (montelukast sodium), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Ketek, and have Sinusitis.
The phase IV clinical study analyzes which people have Hepatitis when taking Singulair. It is created by eHealthMe based on reports of 125,532 people who have side effects when taking Singulair from the FDA, and is updated regularly.
What is Singulair?
Singulair has active ingredients of montelukast sodium. It is often used in asthma. eHealthMe is studying from 129,751 Singulair users. Check the latest studies of Singulair.
What is Hepatitis?
Hepatitis (inflammation of the liver) is found to be associated with 1,494 drugs and 1,521 conditions by eHealthMe. Check the latest studies of Hepatitis.
125,532 people reported to have side effects when taking Singulair.
Among them, 244 people (0.19%) have Hepatitis.
Among these 244 people:
How long have people been on Singulair when they have Hepatitis? *
What is the gender of people who have Hepatitis when taking Singulair? *
What is the age of people who have Hepatitis when taking Singulair? *
What are other drugs people take besides Singulair? *
What are other side effects people have besides Hepatitis? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Singulair and have Hepatitis?
- Check whether Hepatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Singulair:
- Singulair (129,751 reports)
Hepatitis treatments and more:
- Hepatitis (31,197 reports)
How severe was Hepatitis and when was it recovered:
Expand to all the drugs that have ingredients of montelukast sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Singulair:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hepatitis:
- Hepatitis (1,494 drugs)
Browse all the conditions that are associated with Hepatitis:
- Hepatitis (1,521 conditions)
Related publications that referenced our studies
- Mati?, K., & Pele?, A. M. , "Drug-induced toxic hepatitis associated with the combination of quetiapine and fluphenazine: A case report", The European Journal of Psychiatry, 2018 Jan .
- Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .
- Mati?, K., & Pele?, A. M. , "Drug-induced toxic hepatitis associated with the combination of quetiapine and fluphenazine: A case report", The European Journal of Psychiatry, 2018 Jan .
- Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .
How the study uses the data?
The study uses data from the FDA. It is based on montelukast sodium (the active ingredients of Singulair) and Singulair (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lasix cause Pulmonary Function Test Decreased? - a second ago
- Wellbutrin vs. Cymbalta, side effect and effectiveness comparison - a second ago
- Could Rhinocort cause Cardiac Failure Aggravated? - a second ago
- Drug interactions of Cardizem and Epoprostenol Sodium - 3 seconds ago
- Could Remeron cause Insomnia? - 4 seconds ago
- Drug interactions of Topamax and Ultram - 4 seconds ago
- Drug interactions of Oseltamivir Phosphate and Morphine - 4 seconds ago
- Drug interactions of Losartan Potassium and Zocor - 5 seconds ago
- Could Isturisa cause Weakness? - 7 seconds ago
- Could Remicade cause Tumor Lysis Syndrome? - 7 seconds ago